A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations

[1]  Jin Xu,et al.  Four and a Half LIM Domains 1b (Fhl1b) Is Essential for Regulating the Liver versus Pancreas Fate Decision and for β-Cell Regeneration , 2016, PLoS genetics.

[2]  C. Krarup,et al.  Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy , 2015, Brain : a journal of neurology.

[3]  D. Stainier,et al.  Genetic compensation induced by deleterious mutations but not gene knockdowns , 2015, Nature.

[4]  W. Rottbauer,et al.  In vivo characterization of human myofibrillar myopathy genes in zebrafish. , 2015, Biochemical and biophysical research communications.

[5]  C. Mitchell,et al.  FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation , 2014, Journal of Cell Science.

[6]  Alan H Beggs,et al.  Analysis of skeletal muscle defects in larval zebrafish by birefringence and touch-evoke escape response assays. , 2013, Journal of visualized experiments : JoVE.

[7]  J. Kautzner,et al.  Isolated X-Linked Hypertrophic Cardiomyopathy Caused by a Novel Mutation of the Four-and-a-Half LIM Domain 1 Gene , 2013, Circulation. Cardiovascular genetics.

[8]  M. Papadaki,et al.  Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patients. , 2013, Human molecular genetics.

[9]  Steven B Marston,et al.  Skeletal muscle myopathy mutations at the actin tropomyosin interface that cause gain- or loss-of-function , 2013, Journal of Muscle Research and Cell Motility.

[10]  J. Schessl,et al.  Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy , 2013, Neuromuscular Disorders.

[11]  J. Vincent,et al.  Spongious Hypertrophic Cardiomyopathy in Patients With Mutations in the Four-and-a-Half LIM Domain 1 Gene , 2012, Circulation. Cardiovascular genetics.

[12]  Eloisa Arbustini,et al.  Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. , 2012, Human molecular genetics.

[13]  J. Schessl,et al.  Reducing body myopathy and other FHL1-related muscular disorders. , 2011, Seminars in pediatric neurology.

[14]  C. Mitchell,et al.  Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: A comprehensive review of the clinical, histological and pathological features , 2011, Neuromuscular Disorders.

[15]  W. Rottbauer,et al.  JunB-CBFβ signaling is essential to maintain sarcomeric Z-disc structure and when defective leads to heart failure , 2010, Journal of Cell Science.

[16]  W. Schaper,et al.  A Common MLP (Muscle LIM Protein) Variant Is Associated With Cardiomyopathy , 2010, Circulation research.

[17]  W. Rottbauer,et al.  Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy , 2009, Nature Medicine.

[18]  W. Rottbauer,et al.  A Single Serine in the Carboxyl Terminus of Cardiac Essential Myosin Light Chain-1 Controls Cardiomyocyte Contractility In Vivo , 2009, Circulation research.

[19]  F. Muntoni,et al.  Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. , 2009, Brain : a journal of neurology.

[20]  I. Ferrer,et al.  Molecular pathology of myofibrillar myopathies , 2008, Expert Reviews in Molecular Medicine.

[21]  J. Golden,et al.  Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. , 2008, The Journal of clinical investigation.

[22]  T. Evans,et al.  Gata5 and Gata6 are functionally redundant in zebrafish for specification of cardiomyocytes. , 2007, Developmental biology.

[23]  W. Rottbauer,et al.  Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart. , 2006, Genes & development.

[24]  B. Gersh,et al.  Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. , 2006, Molecular genetics and metabolism.

[25]  Susan S. Brown,et al.  Four and a Half LIM Protein 1 Binds Myosin-binding Protein C and Regulates Myosin Filament Formation and Sarcomere Assembly* , 2006, Journal of Biological Chemistry.

[26]  W. Rottbauer,et al.  VEGF–PLCγ1 pathway controls cardiac contractility in the embryonic heart , 2005 .

[27]  R. Schwartz,et al.  Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. , 2003, Molecular genetics and metabolism.

[28]  R. Dietz,et al.  Mutations in the Human Muscle LIM Protein Gene in Families With Hypertrophic Cardiomyopathy , 2003, Circulation.

[29]  F. B. Pickett,et al.  Splitting pairs: the diverging fates of duplicated genes , 2002, Nature Reviews Genetics.

[30]  L. Lettice,et al.  Whole-mount in situ hybridizations on zebrafish embryos using a mixture of digoxigenin- and fluorescein-labelled probes. , 1994, Trends in genetics : TIG.

[31]  J. Seidman,et al.  Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice. , 2014, Human molecular genetics.

[32]  W. Rottbauer,et al.  Fishing for the genetic basis of cardiovascular disease , 2009, Disease Models & Mechanisms.